Literature DB >> 21276915

The arterial distribution of Embozene and Embosphere microspheres in sheep kidney and uterus embolization models.

Valentin Verret1, Saïda Homayra Ghegediban, Michel Wassef, Jean Pierre Pelage, Jafar Golzarian, Alexandre Laurent.   

Abstract

PURPOSE: To compare the in vivo distribution of the new embolic Embozene versus Embosphere as a control in the sheep renal and uterine vasculature.
MATERIALS AND METHODS: Twelve sheep (three per group of product and size) were selectively embolized with Embozene 700 μm, Embozene 900 μm, Embosphere 500-700 μm, or Embosphere 700-900 μm, in one renal artery (0.5 mL microspheres) and in the two uterine arteries (0.25 mL each) and sacrificed 72 hours later for pathologic examination of kidney and uterus. Partition of microspheres in the vasculature was determined according to a classification of the renal and the uterine vasculatures into several zones. Vascular diameters and microsphere deformation were measured.
RESULTS: Embozene 700 μm and Embozene 900 μm occluded significantly more distally than Embosphere 500-700 μm and Embosphere 700-900 μm in renal and uterine vasculature. For Embozene, the vessel diameter was not significantly different between the two sizes, for each organ, whereas it was significantly larger for Embosphere 700-900 μm than for Embosphere 500-700 μm in each organ. Embozene deformation was significantly higher than that of Embosphere in renal and uterine vasculature, increased from proximal to distal in location for both organs and correlated negatively with vessel diameter (Rho = -0.623; P < .0001). Embosphere deformation did not vary according to the zone.
CONCLUSIONS: Embozene microspheres have a higher in vivo deformation, which results in a more distal occlusion within the vascular network compared with reference Embosphere microspheres. The diameter of occluded vessels varied for the tested size range for Embosphere but was independent of the tested microsphere size range used for Embozene. The deformation of Embozene appears to determine the size of the vessels occluded as opposed to the granulometric particle size, which makes level of occlusion unpredictable.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276915     DOI: 10.1016/j.jvir.2010.10.021

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  14 in total

Review 1.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

2.  In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.

Authors:  Baosheng Ren; Wansheng Wang; Jian Shen; Caifang Ni; Xiaoli Zhu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 3.  Particle Distribution in Embolotherapy, How Do They Get There? A Critical Review of the Factors Affecting Arterial Distribution of Embolic Particles.

Authors:  Reza Talaie; Pooya Torkian; Omid Amili; Yasmina Aboufirass; Nassir Rostambeigi; Hamed Jalaeian; Jafar Golzarian
Journal:  Ann Biomed Eng       Date:  2022-05-06       Impact factor: 3.934

Review 4.  Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Guorong Jia; Juno Van Valkenburgh; Austin Z Chen; Quan Chen; Jindian Li; Changjing Zuo; Kai Chen
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-08-17

5.  Embolization of meningiomas: comparison of safety between calibrated microspheres and polyvinyl-alcohol particles as embolic agents.

Authors:  M Sluzewski; W J van Rooij; P N Lohle; G N Beute; J P Peluso
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-18       Impact factor: 3.825

6.  Clinical evaluation of embolization of the superior vesical prostatic artery for treatment of benign prostatic hyperplasia: a single-center retrospective study.

Authors:  Zhilei Qiu; Changcun Zhang; Xinsheng Wang; Kai Cheng; Xin Liang; Dawen Wang; Sichuan Hou; Xinsheng Wang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-12-29       Impact factor: 1.195

7.  Microfluidic-prepared, monodisperse, X-ray-visible, embolic microspheres for non-oncological embolization applications.

Authors:  Cyrus W Beh; Yingli Fu; Clifford R Weiss; Charles Hu; Aravind Arepally; Hai-Quan Mao; Tza-Huei Wang; Dara L Kraitchman
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

8.  Primary bilateral ovarian artery embolization for uterine leiomyomatosis in the setting of a rare anatomic variant - hypoplastic uterine arteries.

Authors:  Merve Ozen; Shezaan Momin; Charles Ben Myers; Mark Hoffman; Driss Raissi
Journal:  Radiol Case Rep       Date:  2021-07-02

9.  Universal behavior of hydrogels confined to narrow capillaries.

Authors:  Yang Li; Ozan S Sarıyer; Arun Ramachandran; Sergey Panyukov; Michael Rubinstein; Eugenia Kumacheva
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

10.  DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.

Authors:  Andrew L Lewis; Matthew R Dreher; Vincent O'Byrne; David Grey; Marcus Caine; Anthony Dunn; Yiqing Tang; Brenda Hall; Kirk D Fowers; Carmen Gacchina Johnson; Karun V Sharma; Bradford J Wood
Journal:  J Mater Sci Mater Med       Date:  2015-12-16       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.